Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2024-03-07 Remuneration Information
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2023
Remuneration Information Classification · 100% confidence The document text is heavily focused on explaining the company's remuneration policy ('POLÍTICA DE REMUNERACIONES'), detailing how compensation for directors and executives is determined, including fixed vs. variable components, performance metrics, use of external advisors (Mercer, Willis Towers Watson), and alignment with long-term strategy. This content directly corresponds to the disclosure requirements for executive and director compensation, which is typically found in a Remuneration Report or Proxy Statement related to compensation matters. Given the specific focus on the remuneration policy ('A. POLÍTICA DE REMUNERACIONES DE LA SOCIEDAD PARA EL EJERCICIO EN CURSO') and the detailed breakdown of compensation structures, the most appropriate classification is 'Remuneration Information' (DEF 14A), which covers compensation details for top executives and directors, often disclosed in proxy materials.
2024-03-07 Spanish
Corporate Governance Report - Grifols S.A.
Remuneration Information Classification · 100% confidence The document text is heavily focused on explaining the company's remuneration policy ('POLÍTICA DE REMUNERACIONES'), detailing how compensation for directors and executives is determined, including fixed vs. variable components, performance metrics, use of external advisors (Mercer, Willis Towers Watson), and alignment with long-term strategy. This content directly corresponds to the disclosure requirements for executive and director compensation, which is typically found in a Remuneration Report or Proxy Statement related to compensation matters. Given the specific focus on the remuneration policy ('A. POLÍTICA DE REMUNERACIONES DE LA SOCIEDAD PARA EL EJERCICIO EN CURSO') and the detailed breakdown of compensation structures, the most appropriate classification is 'Remuneration Information' (DEF 14A), which covers compensation details for top executives and directors, often disclosed in proxy materials.
2024-03-07 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) conducted by a Director/Executive (Thomas Glanzmann, Presidente Ejecutivo y Consejero Delegado) in the company's shares. This directly corresponds to the definition of Director's Dealing, which is classified as 'DIRS'.
2024-03-07 Spanish
FORM 6-K
Regulatory Filings
2024-03-01 English
FORM 6-K
Regulatory Filings
2024-03-01 English
FORM 6-K
Regulatory Filings
2024-03-01 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.